Evidence map›Paper›PMID 40041904›Full record

ArticleActa pharmaceutica Sinica. B2025

DiPTAC: A degradation platform

Yutong Tu, Qian Yu, Mengna Li, Lixin Gao, Jialuo Mao, Jingkun Ma, Xiaowu Dong, Jinxin Che, Chong Zhang, Linghui Zeng and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Oleanolic Acid Amide Derivatives as 20s Proteasome Stimulators.Chembiochem : a European journal of chemical biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yutong TuZhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
Qian YuSchool of Medicine, Hangzhou City University, Hangzhou 310015, China.
Mengna LiZhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
Lixin GaoSchool of Life ScienceS and Health Engineering, Jiangnan University, Wuxi 214122, China.
Jialuo MaoZhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
Jingkun MaZhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
Xiaowu DongCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Jinxin CheCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Chong ZhangSchool of Medicine, Hangzhou City University, Hangzhou 310015, China.
Linghui ZengSchool of Medicine, Hangzhou City University, Hangzhou 310015, China.
Huajian ZhuSchool of Medicine, Hangzhou City University, Hangzhou 310015, China.
Jiaan ShaoSchool of Medicine, Hangzhou City University, Hangzhou 310015, China.
Jingli HouInstrumental AnalysiS Center of Shanghai Jiao Tong University, Shanghai 200240, China.
Liming HuKey Laboratory of SystemS Biomedicine (Ministry of Education), Shanghai Center for SystemS Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, China.
Bingbing WanKey Laboratory of SystemS Biomedicine (Ministry of Education), Shanghai Center for SystemS Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, China.
Jia LiZhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
Yubo ZhouZhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
Jiankang ZhangSchool of Medicine, Hangzhou City University, Hangzhou 310015, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DiPTACE3PROTACProteasomeTargeted protein degradation

Identifiers

PMID40041904
PMCPMC11873643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.